Molecular imaging of innate immunity and immunotherapy

Adv Drug Deliv Rev. 2023 Jul:198:114865. doi: 10.1016/j.addr.2023.114865. Epub 2023 May 13.

Abstract

The innate immune system plays a key role as the first line of defense in various human diseases including cancer, cardiovascular and inflammatory diseases. In contrast to tissue biopsies and blood biopsies, in vivo imaging of the innate immune system can provide whole body measurements of immune cell location and function and changes in response to disease progression and therapy. Rationally developed molecular imaging strategies can be used in evaluating the status and spatio-temporal distributions of the innate immune cells in near real-time, mapping the biodistribution of novel innate immunotherapies, monitoring their efficacy and potential toxicities, and eventually for stratifying patients that are likely to benefit from these immunotherapies. In this review, we will highlight the current state-of-the-art in noninvasive imaging techniques for preclinical imaging of the innate immune system particularly focusing on cell trafficking, biodistribution, as well as pharmacokinetics and dynamics of promising immunotherapies in cancer and other diseases; discuss the unmet needs and current challenges in integrating imaging modalities and immunology and suggest potential solutions to overcome these barriers.

Keywords: Dendritic cells; Immunotherapy; Innate immunity; Macrophages; Molecular imaging.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Immunity, Innate*
  • Immunotherapy / methods
  • Molecular Imaging
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / therapy
  • Tissue Distribution